Mitomycin C and Corneal Fibroblasts
Author Information
Author(s): Kim Tae-im, Choi Seung-il, Lee Hyung Keun, Cho Young Jae, Kim Eung Kweon
Primary Institution: Corneal Dystrophy Research Institute, Department of Ophthalmology, Yonsei University, College of Medicine, Seoul, Korea
Hypothesis
The study investigates the effect of mitomycin C (MMC) on cell viability, apoptosis, and TGFBIp expression in corneal fibroblasts from patients with granular corneal dystrophy type II.
Conclusion
Mitomycin C induced apoptosis in corneal fibroblasts, particularly affecting GCD II homozygote cells, and reduced TGFBIp production across all cell types.
Supporting Evidence
- MMC reduced cell viability in a dose-dependent and time-dependent manner.
- FACS analysis showed that MMC caused apoptosis, especially in GCD II homozygote cells.
- MMC decreased Bcl-xL mRNA expression and increased Bax mRNA expression in all cell types.
- MMC reduced TGFBI mRNA levels and TGFBIp protein levels in all cell types.
Takeaway
Mitomycin C can make certain corneal cells die, especially in patients with a specific type of corneal disease, and it also lowers a protein that can cause problems in the eye.
Methodology
Corneal fibroblasts were cultured from normal and GCD II patients, treated with MMC, and analyzed for cell viability and apoptosis using various assays.
Limitations
The study was conducted in vitro, and results may not fully represent responses in living corneas.
Participant Demographics
Corneal fibroblasts were derived from normal individuals and patients with heterozygote or homozygote granular corneal dystrophy type II.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website